Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Drugs for Treatment of Asthma Market Research Report to 2020

  • QYR617839
  • 121 Pages
  • June 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
This report studies Drugs for Treatment of Asthma in Global market, especially in USA, EU, China, Japan, Southeast Asia and India, focuses on top players in these countries, with production, price, revenue and market share in Global market, like

Merck Sharp &

Glaxo

AstraZeneca

Boehringer Ingelheim Pharma GmbH &

Otsuka

Lunan Pharmaceutical Group Corporation

Daiichi-Sankyo

Sea Derun Pharmaceutical Group

Beijing Double-Crane Pharmaceutical Modern Technology

Jewim Pharma

Yangzhou three drugs Pharmaceutical

Hubei Hengan Fulin Pharma

Xianju Pharma

Bright Future Pharmaceuticals Factory

Market Segment by Regions, this report splits Global into several key countries, with production, consumption, revenue, market share and growth rate of Drugs for Treatment of Asthma in these countries, from 2011 to 2020 (forecast), like

USA

China

EU

Japan

Southeast Asia

India

Rest of Global

Split by product types, with production, revenue, price, market share and growth rate of each type, can be divided into

Montelukast Sodium Chewable Tablets

Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation

Salbutamol Sulphate Aerosol

Compound Methoxyphenamine Capsules

Budesonide Suspension for Inhalation

Budesonide and Formoterol Fumarate Powder for Inhalation

Budesonide and Formoterol Fumarate Powder for Inhalation

Ipratropium Bromide Aerosol

Salbutamol Aerosol

Fluticasone Propionate Inhaled Aerosol

Split by applications, this report focuses on consumption, market share and growth rate of Drugs for Treatment of Asthma in each application, can be divided into

Bronchial Asthma

Asthmatic Bronchitis

Bronchogenic Carcinoma

Cardiac Asthma

Table of Contents

Global Drugs for Treatment of Asthma Market Research Report to 2020

1 Drugs for Treatment of Asthma Overview

1.1 Product Overview and Scope of Drugs for Treatment of Asthma

1.2 Drugs for Treatment of Asthma Segment by Type

1.2.1 Montelukast Sodium Chewable Tablets and Production Growth Rate 2011-2020

1.2.2 Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation and Production Growth Rate 2011-2020

1.2.3 Salbutamol Sulphate Aerosol and Production Growth Rate 2011-2020

1.2.4 Compound Methoxyphenamine Capsules and Production Growth Rate 2011-2020

1.2.5 Budesonide Suspension for Inhalation and Production Growth Rate 2011-2020

1.2.6 Budesonide Suspension for Inhalation and Production Growth Rate 2011-2020

1.2.7 Ipratropium Bromide Aerosol and Production Growth Rate 2011-2020

1.2.8 Ipratropium Bromide Aerosol and Production Growth Rate 2011-2020

1.2.9 Salbutamol Aerosol and Production Growth Rate 2011-2020

1.2.10 Fluticasone Propionate Inhaled Aerosol and Production Growth Rate 2011-2020

1.3 Drugs for Treatment of Asthma Segment by Applications

1.3.1 Drugs for Treatment of Asthma Consumption Market Share by Applications in 2015 and 2016

1.3.2 Bronchial Asthma and Key Clients (Buyers) List

1.3.3 Asthmatic Bronchitis and Key Clients (Buyers) List

1.3.4 Bronchogenic Carcinoma and Key Clients (Buyers) List

1.3.5 Cardiac Asthma and Key Clients (Buyers) List

1.4 Drugs for Treatment of Asthma Market by Regions

1.4.1 USA Status and Prospect 2011-2020

1.4.2 China Status and Prospect 2011-2020

1.4.3 EU Status and Prospect 2011-2020

1.4.4 Japan Status and Prospect 2011-2020

1.4.5 Southeast Asia Status and Prospect 2011-2020

1.4.6 India Status and Prospect 2011-2020

1.5 Global Market Size (Value and Volume) of Drugs for Treatment of Asthma 2011-2020

1.5.1 Global Drugs for Treatment of Asthma Capacity, Production and Growth Rate 2011-2020

1.5.2 Global Drugs for Treatment of Asthma Revenue and Growth Rate 2011-2020

2 Global Drugs for Treatment of Asthma Market Competition by Manufacturers

2.1 Global Drugs for Treatment of Asthma Production and Share by Manufacturers (2015 and 2016)

2.2 Global Drugs for Treatment of Asthma Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Drugs for Treatment of Asthma Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Drugs for Treatment of Asthma Manufacturing Base Distribution and Product Type

3 Global Drugs for Treatment of Asthma Market Analysis by Type and Applications

3.1 Global Drugs for Treatment of Asthma Production, Market Share and Growth Rate by Type (2011-2020)

3.2 Global Drugs for Treatment of Asthma Revenue, Market Share and Growth Rate by Type (2011-2020)

3.3 Drugs for Treatment of Asthma Average Price by Type in 2015

3.4 Global Drugs for Treatment of Asthma Consumption, Market Share and Growth Rate by Applications 2011-2020

4 Global Drugs for Treatment of Asthma Manufacturers Analysis

4.1 Merck Sharp &

4.1.1 Company Basic Information, Manufacturing Base and Competitors

4.1.2 Product Type and Technology of Merck Sharp &

4.1.2.1 Simvastatin Tablets Price and Specification

4.1.2.2 Losartan Potassium Tablets and Fluticasone Propionate Powder for Inhalation Price and Specification

4.1.2.3 Injection Imipenem Price and Specification

4.1.3 Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Merck Sharp & 2015 to 2016

4.2 Glaxo

4.2.1 Company Basic Information, Manufacturing Base and Competitors

4.2.2 Product Type and Technology of Glaxo

4.2.2.1 Ceftazidime Price and Specification

4.2.2.2 Cefuroxime Axetil Price and Specification

4.2.2.3 Adefovir Dipivoxil Tablets Price and Specification

4.2.3 Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Glaxo 2015 to 2016

4.3 AstraZeneca

4.3.1 Company Basic Information, Manufacturing Base and Competitors

4.3.2 Product Type and Technology of AstraZeneca

4.3.2.1 Isosorbide Dinitrate Sustained-ReleaseTablets Price and Specification

4.3.2.2 Omeprazole Price and Specification

4.3.2.3 Felodipine Sustained Release Tablets Price and Specification

4.3.3 Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of AstraZeneca 2015 to 2016

4.4 Boehringer Ingelheim Pharma GmbH &

4.4.1 Company Basic Information, Manufacturing Base and Competitors

4.4.2 Product Type and Technology of Boehringer Ingelheim Pharma GmbH &

4.4.2.1 Mucosolvan Price and Specification

4.4.2.2 Linagliptin Tablets Price and Specification

4.4.2.3 Telmisartan Price and Specification

4.4.3 Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Boehringer Ingelheim Pharma GmbH & 2015 to 2016

4.5 Otsuka

4.5.1 Company Basic Information, Manufacturing Base and Competitors

4.5.2 Drugs for Treatment of Asthma Product Type and Technology

4.5.2.1 Parenteral Nutrition Price and Specification

4.5.2.2 Compound Amino Acid Injection (18AA-?) Price and Specification

4.5.2.3 Compound Electrolytes Injection Price and Specification

4.5.3 Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Otsuka 2015 to 2016

4.6 Lunan Pharmaceutical Group Corporation

4.6.1 Company Basic Information, Manufacturing Base and Competitors

4.6.2 Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Lunan Pharmaceutical Group Corporation 2015 to 2016

4.7 Daiichi-Sankyo

4.7.1 Company Basic Information, Manufacturing Base and Competitors

4.7.2 Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Daiichi-Sankyo 2015 to 2016

4.8 Sea Derun Pharmaceutical Group

4.8.1 Company Basic Information, Manufacturing Base and Competitors

4.8.2 Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Sea Derun Pharmaceutical Group 2015 to 2016

4.9 Beijing Double-Crane Pharmaceutical Modern Technology

4.9.1 Company Basic Information, Manufacturing Base and Competitors

4.9.2 Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Beijing Double-Crane Pharmaceutical Modern Technology 2015 to 2016

4.10 Jewim Pharma

4.10.1 Company Basic Information, Manufacturing Base and Competitors

4.10.2 Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Jewim Pharma 2015 to 2016

4.11 Yangzhou three drugs Pharmaceutical

4.11.1 Company Basic Information, Manufacturing Base and Competitors

4.11.2 Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Yangzhou three drugs Pharmaceutical 2015 to 2016

4.12 Hubei Hengan Fulin Pharma

4.12.1 Company Basic Information, Manufacturing Base and Competitors

4.12.2 Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Hubei Hengan Fulin Pharma 2015 to 2016

4.13 Xianju Pharma

4.13.1 Company Basic Information, Manufacturing Base and Competitors

4.13.2 Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Xianju Pharma 2015 to 2016

4.14 Bright Future Pharmaceuticals Factory

4.14.1 Company Basic Information, Manufacturing Base and Competitors

4.14.2 Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Bright Future Pharmaceuticals Factory 2015 to 2016

5 Global Drugs for Treatment of Asthma Market Analysis by Regions 2011-2020

5.1 Global Drugs for Treatment of Asthma Production by Regions 2011-2020

5.2 Global Drugs for Treatment of Asthma Revenue by Regions 2011-2020

5.3 Global Drugs for Treatment of Asthma Consumption by Regions 2011-2020

5.4 USA Drugs for Treatment of Asthma Production, Consumption and Growth Rate 2011-2020

5.5 China Drugs for Treatment of Asthma Production, Consumption and Growth Rate 2011-2020

5.6 EU Drugs for Treatment of Asthma Production, Consumption and Growth Rate 2011-2020

5.7 Japan Drugs for Treatment of Asthma Production, Consumption and Growth Rate 2011-2020

5.8 Southeast Asia Drugs for Treatment of Asthma Production, Consumption and Growth Rate 2011-2020

5.9 India Drugs for Treatment of Asthma Production, Consumption and Growth Rate 2011-2020

6 Drugs for Treatment of Asthma Technology and Development Trend

6.1 Drugs for Treatment of Asthma Technology Analysis

6.2 Drugs for Treatment of Asthma Technology Development Trend

7 Research Findings and Conclusion

List Of Tables and Figures

Figure Picture of Drugs for Treatment of Asthma

Figure Picture of Montelukast Sodium Chewable Tablets

Figure Montelukast Sodium Chewable Tablets Production Growth Rate 2011-2020

Figure Picture of Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation

Figure Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation Production Growth Rate 2011-2020

Figure Picture of Salbutamol Sulphate Aerosol

Figure Salbutamol Sulphate Aerosol Production Growth Rate 2011-2020

Figure Picture of Compound Methoxyphenamine Capsules

Figure Compound Methoxyphenamine Capsules Production Growth Rate 2011-2020

Figure Picture of Budesonide Suspension for Inhalation

Figure Budesonide Suspension for Inhalation Production Growth Rate 2011-2020

Figure Picture of Budesonide Suspension for Inhalation

Figure Budesonide Suspension for Inhalation Production Growth Rate 2011-2020

Figure Picture of Ipratropium Bromide Aerosol

Figure Ipratropium Bromide Aerosol Production Growth Rate 2011-2020

Figure Picture of Ipratropium Bromide Aerosol

Figure Ipratropium Bromide Aerosol Production Growth Rate 2011-2020

Figure Picture of Salbutamol Aerosol

Figure Salbutamol Aerosol Production Growth Rate 2011-2020

Figure Picture of Fluticasone Propionate Inhaled Aerosol

Figure Fluticasone Propionate Inhaled Aerosol Production Growth Rate 2011-2020

Table Drugs for Treatment of Asthma Consumption Market Share by Applications in 2015 and 2016

Table Drugs for Treatment of Asthma Key Clients (Buyers) List in Bronchial Asthma

Table Drugs for Treatment of Asthma Key Clients (Buyers) List in Asthmatic Bronchitis

Table Drugs for Treatment of Asthma Key Clients (Buyers) List in Bronchogenic Carcinoma

Table Drugs for Treatment of Asthma Key Clients (Buyers) List in Cardiac Asthma

Figure USA Drugs for Treatment of Asthma Production and Growth Rate 2011-2020

Figure USA Drugs for Treatment of Asthma Consumption and Growth Rate 2011-2020

Figure China Drugs for Treatment of Asthma Production and Growth Rate 2011-2020

Figure China Drugs for Treatment of Asthma Consumption and Growth Rate 2011-2020

Figure EU Drugs for Treatment of Asthma Production and Growth Rate 2011-2020

Figure EU Drugs for Treatment of Asthma Consumption and Growth Rate 2011-2020

Figure Japan Drugs for Treatment of Asthma Production and Growth Rate 2011-2020

Figure Japan Drugs for Treatment of Asthma Consumption and Growth Rate 2011-2020

Figure Southeast Asia Drugs for Treatment of Asthma Production and Growth Rate 2011-2020

Figure Southeast Asia Drugs for Treatment of Asthma Consumption and Growth Rate 2011-2020

Figure India Drugs for Treatment of Asthma Production and Growth Rate 2011-2020

Figure India Drugs for Treatment of Asthma Consumption and Growth Rate 2011-2020

Figure Global Drugs for Treatment of Asthma Capacity, Production and Growth Rate 2011-2020

Figure Global Drugs for Treatment of Asthma Revenue and Growth Rate 2011-2020

Table Global Drugs for Treatment of Asthma Production of Key Manufacturers (2015 and 2016)

Table Global Drugs for Treatment of Asthma Production Share by Manufacturers (2015 and 2016)

Table Global Drugs for Treatment of Asthma Revenue by Manufacturers (2015 and 2016)

Table Global Drugs for Treatment of Asthma Revenue Share by Manufacturers (2015 and 2016)

Table Global Market Drugs for Treatment of Asthma Average Price of Key Manufacturers (2015 and 2016)

Table Manufacturers Drugs for Treatment of Asthma Manufacturing Base Distribution and Product Type

Table Global Drugs for Treatment of Asthma Production by Type (2011-2020)

Table Global Drugs for Treatment of Asthma Production Share by Type (2011-2020)

Table Global Drugs for Treatment of Asthma Production Growth Rate by Type (2011-2020)

Table Global Drugs for Treatment of Asthma Revenue by Type (2011-2020)

Table Global Drugs for Treatment of Asthma Revenue Share by Type (2011-2020)

Table Global Drugs for Treatment of Asthma Revenue Growth Rate by Type (2011-2020)

Table Drugs for Treatment of Asthma Average Price by Type in 2015

Table Global Drugs for Treatment of Asthma Consumption by Asthmatic Bronchitis011-2020

Table Global Drugs for Treatment of Asthma Consumption Market Share by Asthmatic Bronchitis011-2020

Table Global Drugs for Treatment of Asthma Consumption Growth Rate by Asthmatic Bronchitis011-2020

Table Merck Sharp & Basic Information List

Table Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Merck Sharp & 2015 to 2016

Table Glaxo Basic Information List

Table Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Glaxo 2015 to 2016

Table AstraZeneca Basic Information List

Table Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of AstraZeneca 2015 to 2016

Table Boehringer Ingelheim Pharma GmbH & Basic Information List

Table Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Boehringer Ingelheim Pharma GmbH & 2015 to 2016

Table Otsuka Basic Information List

Table Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Otsuka 2015 to 2016

Table Lunan Pharmaceutical Group Corporation Basic Information List

Table Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Lunan Pharmaceutical Group Corporation 2015 to 2016

Table Daiichi-Sankyo Basic Information List

Table Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Daiichi-Sankyo 2015 to 2016

Table Sea Derun Pharmaceutical Group Basic Information List

Table Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Sea Derun Pharmaceutical Group 2015 to 2016

Table Beijing Double-Crane Pharmaceutical Modern Technology Basic Information List

Table Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Beijing Double-Crane Pharmaceutical Modern Technology 2015 to 2016

Table Jewim Pharma Basic Information List

Table Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Jewim Pharma 2015 to 2016

Table Yangzhou three drugs Pharmaceutical Basic Information List

Table Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Yangzhou three drugs Pharmaceutical 2015 to 2016

Table Hubei Hengan Fulin Pharma Basic Information List

Table Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Hubei Hengan Fulin Pharma 2015 to 2016

Table Xianju Pharma Basic Information List

Table Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Xianju Pharma 2015 to 2016

Table Bright Future Pharmaceuticals Factory Basic Information List

Table Drugs for Treatment of Asthma Capacity, Production, Revenue, Price of Bright Future Pharmaceuticals Factory 2015 to 2016

Table Global Drugs for Treatment of Asthma Production by Regions 2011-2020

Table Global Drugs for Treatment of Asthma Production Market Share by Regions 2011-2020

Figure Global Drugs for Treatment of Asthma Production Market Share by Regions 2015

Table Global Drugs for Treatment of Asthma Revenue by Regions 2011-2020

Table Global Drugs for Treatment of Asthma Revenue Market Share by Regions 2011-2020

Figure Global Drugs for Treatment of Asthma Revenue Market Share by Regions 2015

Table Global Drugs for Treatment of Asthma Consumption by Regions 2011-2020

Table Global Drugs for Treatment of Asthma Consumption Market Share by Regions 2011-2020

Figure Global Drugs for Treatment of Asthma Consumption Market Share by Regions 2015

Figure USA Drugs for Treatment of Asthma Production and Growth Rate 2011-2020

Figure USA Drugs for Treatment of Asthma Consumption and Growth Rate 2011-2020

Figure China Drugs for Treatment of Asthma Production and Growth Rate 2011-2020

Figure China Drugs for Treatment of Asthma Consumption and Growth Rate 2011-2020

Figure EU Drugs for Treatment of Asthma Production and Growth Rate 2011-2020

Figure EU Drugs for Treatment of Asthma Consumption and Growth Rate 2011-2020

Figure Japan Drugs for Treatment of Asthma Production and Growth Rate 2011-2020

Figure Japan Drugs for Treatment of Asthma Consumption and Growth Rate 2011-2020

Figure Southeast Asia Drugs for Treatment of Asthma Production and Growth Rate 2011-2020

Figure Southeast Asia Drugs for Treatment of Asthma Consumption and Growth Rate 2011-2020

Figure India Drugs for Treatment of Asthma Production and Growth Rate 2011-2020

Figure India Drugs for Treatment of Asthma Consumption and Growth Rate 2011-2020

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390